Lyudmila Bazhenova, MD of UC San Diego Health discusses what physicians should expect when treating ALK positive lung cancer patients with ALK inhibitors at the 2017 Annual Meeting Annual Meeting in Chicago, IL.
What outcomes can physicians expect when treating ALK+ lung cancer patients with ALK inhibitors
